FOXO1 might be implicated in the development or progression of type 2 diabetes, since increased FOXO1 expression in diabetic mouse liver is associated with increased expression of PEPCK and G6Pase, and inhibition of FOXO1 activity downregulated both PEPCK and G6Pase expression and normalized the blood glucose levels. Here, PCK2 is linked to type 2 diabetes mellitus.